Clinical Trials: Glioblastoma multiforme

Duarte : City of Hope

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Irvine : UCI Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

La Jolla : University of California San Diego Moores Cancer Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

La Jolla : UCSD Moores Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Los Angeles : Research Site

AMG 595 First-in-Human in Recurrent Gliomas

View More »

Los Angeles : University of California, Los Angeles

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Los Angeles : University of Southern California

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Los Angeles : UCLA

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Los Angeles : UCLA

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Los Angeles : Cedars-Sinai Medical Center-Samuel Oschin Comprehensive Cancer Institute

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Los Angeles : UCLA Neuro-Oncology Program

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Newport Beach : Hoag Memorial Hospital Presbyterian

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Orange : UCI Medical Center

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Sacramento : Sutter Institute for Medical Research

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

San Francisco : University of California at San Francisco

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

San Francisco : University of California at San Francisco

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

South Pasadena : South Pasadena Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Aurora : University of Colorado Denver, University of Colorado Cancer Center

Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme

Aurora : University of Colorado Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Washington : Georgetown University Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Ft. Myers : Florida Cancer Specialists

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Miami Beach : Mount Sinai CCOP

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Orlando : MD Anderson Cancer Center Orlando

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Pensacola : Woodlands Medical Specialists

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Sarasota : Florida Cancer Specialists

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor

View More »

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Tampa : Moffitt Cancer Center & Research Institute

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Savannah : Memorial University Medical Center

RTOG-0913: Phase I/II Trial of Concurrent RAD001 (Everolimus) With Temozolomide/Radiation Followed by Adjuvant RAD001/Temozolomide in Newly Diagnosed Glioblastoma

View More »

Atlanta : Emory University, Winship Cancer Institute

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Chicago : Northwestern University Feinberg School of Medicine

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Chicago : University of Illinois at Chicago

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Chicago : University of Illinois Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chicago : Rush University Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chicago : Northwestern University - Robert H Lurie Comprehensive Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

View More »

Peoria : Illinois Cancer Care

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Indianapolis : IU Simon Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Lexington : University of Kentucky, Markey Cancer Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Lexington : University of Kentucky - Markey Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Scarborough : Maine Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Baltimore : The Johns Hopkins Hospital

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Bethesda : Center for Cancer and Blood Disorders

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Boston : Dana-Farber Cancer Institute

Amgen 386 for Recurrent Glioblastoma

Boston : Tufts Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Boston : Dana-Farber Cancer Institute

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Boston : Massachusetts General Hospital

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Boston : Tufts Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

View More »

Burlington : Lahey Clinic Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Ann Arbor : University of Michigan, Department of Neurosurgery

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Detroit : Henry Ford Health Systems

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Detroit : Henry Ford Health System

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Detroit : Henry Ford Hospital

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Detroit : Henry Ford Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

View More »

Detroit : Henry Ford Hospital

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Minneapolis : Virginia Piper Cancer Institute

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Kansas City : St. Luke's Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

St. Louis : Washington University School of Medicine, Division of Oncology

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

St. Louis : Washington University School of Medicine

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Edison : New Jersey Neuroscience Center - JFK Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Edison : JFK Medical Center

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Hackensack : John Theurer Cancer Center at Hackensack University

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

View More »

Summit : Overlook Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Manhasset : Biomedical Research Alliance of New York

Glioblastoma (Brain Tumor) and Unmethylated MGMT Gene - Adults

Manhasset : Biomedical Research Alliance of New York

Glioblastoma Multiforme (Brain Cancer) - Adults

Manhasset : Biomedical Research Alliance of New York

If you have a brain tumor, you may be eligible to participate in a research study being conducted by North Shore-Long Island Jewish Health System.

View More »

Amherst : Dent Neurologic Institute

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Commack, Great Neck : Long Island Brain Tumor Centre at Neurological Surgery P.C.

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Huntington : Huntington Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Lake Success : North Shore - Long Island Jewish Hospital/Monter Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Manhasset : North Shore University Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Mineola : Winthrop University Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New York : Investigational Site Number 165464

A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

New York : Mount Sinai Medical Center, Department of Neurosurgery

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

New York : Columbia University Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

New York : Weill Cornell Medical College

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

New York : The New York Hospital/ Weill Medical College

Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

New York : New York University Clinical Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New York : NYU Cancer Institute

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Oceanside : South Nassau Community Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Rochester : University of Rochester Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Rockville Centre : Mercy Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chapel Hill : University of North Carolina

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Durham : The Preston Robert Tisch Brain Tumor Center

AMG 102 and Avastin for Recurrent Malignant Glioma

Durham : Duke University Medical Center

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Winston-Salem : Derrick L Davis Forsyth Regional Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Cincinnati : Research Site

AMG 595 First-in-Human in Recurrent Gliomas

Cincinnati : University of Cincinnati

Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients

Cincinnati : UC Cancer Institute

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Cleveland : Cleveland Clinic Taussig Cancer Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Cleveland : Cleveland Clinic

Evaluation of TRC105 In The Treatment Of Recurrent Glioblastoma After Prior Antiangiogenic Therapy (Including Anti-VEGF Therapy)

View More »

Cleveland : University Hospitals of Cleveland

Evaluation of TRC105 In The Treatment Of Recurrent Glioblastoma After Prior Antiangiogenic Therapy (Including Anti-VEGF Therapy)

Cleveland : Fairview Hospital Moll Cancer Center/Cleveland Clinic

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Cleveland : Cleveland Clinic

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Cleveland : Cleveland Clinic Foundation

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Cleveland : University Hospitals of Cleveland

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Cleveland : Cleveland Clinic Foundation

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Columbus : Ohio State University

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Columbus : The Ohio State University - James Comprehensive Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Mayfield : Hillcrest Hospital Hirsh Cancer Center/Cleveland Clinic

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Portland : Oregon Health and Sciences University

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Portland : Providence Cancer Center

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Danville : Geisinger Health System

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Philadelphia : Hospital of the University of Pennsylvania

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Philadelphia : Pennsylvania Hospital

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Pittsburgh : University of Pittsburgh Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Providence : Rhode Island Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Charleston : Medical University of South Carolina Hospitals and Clinics

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Nashville : Tennessee Oncology

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Nashville : Sarah Cannon Research Institute

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor

Nashville : St. Thomas Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Nashville : Vanderbilt Ingram Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Nashville : Sarah Cannon Research Institute (SCRI) Drug Development Unit

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

View More »

Nashville : Sarah Cannon Research Institute (SCRI)

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Dallas : Baylor Research Institute

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Dallas : Baylor

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Dallas : Baylor Research Institute

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Dallas : Mary Crowley Cancer Research Centers

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Houston : The University of Texas Health Science Center at Houston

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

View More »

Houston : Methodist Hospital

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Houston : Methodist Neurological Institute

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Houston : UT MD Anderson Cancer Center

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Houston : UT MD Anderson Cancer Center

Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)

The Woodlands : Memorial Hermann The Woodlands

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Richmond : Virginia Cancer Institute

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Tacoma : MultiCare Health System

A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain

View More »

Seattle : Swedish Neuroscience Institute

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Seattle : Swedish Hospital Neuroscience Research

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Seattle : Swedish Neuroscience Institute

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Parkville : Research Site

AMG 595 First-in-Human in Recurrent Gliomas

Feldkirch : Landeskrankenhaus Feldkirch

Dendritic Cell Cancer Vaccine for High-grade Glioma

Graz : University Hospital Graz

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Innsbruck : Medical University Innsbruck

Dendritic Cell Cancer Vaccine for High-grade Glioma

Linz : Landesnervenklinik Wagner-Jauregg

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : Kaiser Franz-Josef Spital

Dendritic Cell Cancer Vaccine for High-grade Glioma

View More »

Vienna : Medical University Vienna

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : Donauspital, SMZ-Ost

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : Medical University of Vienna

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Prague : Jan Sroubek

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Lyon : Hospital of Neurology Lyon - University Claude Bernard

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Paris : Group Hospitals Pitie-Salpetriere

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Toulouse : Centre Hospitalo-Universitaire de Toulouse Purpan

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Toulouse Cedex : Institut Claudius Régaud

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Villejuif Cedex : Institut Gustave Roussy, Dept. of Medicine

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Berlin :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Bochum :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Bonn :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Chemnitz :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Dresden :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

View More »

Düsseldorf :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Erfurt :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Erlangen :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Frankfurt :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Freiburg :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Göttingen :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Hamburg : University Medical Center Hamburg-Eppendorf

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Heidelberg : Medical University Heidelberg

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Heidelberg : Department of Neurosurgery, University Hospital Heidelberg

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.

Heidelberg : University of Heidelberg

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Idar-oberstein :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Kiel :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Kiel : University Hospital of Schleswig-Holstein

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Koeln :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Leipzig :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Mannheim :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Muenchen :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

München :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Münster :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Regensburg :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Tübingen :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

ULM :

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Ahmedabad : Gujarat Cancer Research Institute

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Jaipur : Bhagwan Mahaveer Cancer Hospital & Reseach Centre

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Kolkata : Chittaranjan National Cencer Institute

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Mumbai : Jaslok Hospital & Research Centre

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Tel Aviv : Tel Aviv Sourasky Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Lecco : Ospedale Lecco

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Milan : Foundation Hospital Greater Policlinico

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Milan : C. Besta Neurological Institute

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Rome : Istituti Fisioterapici Ospitalieri - Istituto Nazionale dei Tumori Regina Elena

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Barcelona : Hospital Universitari de Bellvitge-ICO Duran i Reynals

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Salamanca : Hospital Universitario de Salamanca

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Seville : Servicio de Oncologia Medica Sala de Investigación

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Lausanne : Centre Hospitalier Universitaire Vaudois (CHUV)

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Kaohisung :

An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse

Taipei :

An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse